Literature DB >> 2842404

BK and JC virus infections in recipients of bone marrow transplants.

R R Arthur1, K V Shah, P Charache, R Saral.   

Abstract

Fifty-five recipients of bone marrow transplants were monitored prospectively for urinary excretion of BK (BKV) and JC (JCV) viruses and for infections with other viruses. For both BKV and JCV, viruria occurred exclusively in patients who were seropositive at transplantation, a finding indicating that shedding of virus was very likely the result of reactivation. BKV reactivation, which occurred in 26 (55%) of 47 BKV-seropositive patients, was far more common than JCV reactivation, which was detected in only two (7%) of 30 JCV-seropositive patients (P less than .0001). In most patients, BK viruria began two to eight weeks after transplantation and resolved spontaneously after a two- to three-week period. Posttransplantation, there was a temporal pattern in the onsets of infection with the different viruses; herpes simplex virus infections occurred first (mean, 7 d), followed by BKV infections (mean, 33 d) and then cytomegalovirus infections (mean, 51 d). BK viruria was associated with hemorrhagic cystitis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2842404     DOI: 10.1093/infdis/158.3.563

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

1.  Detection of BK polyomavirus genotypes in healthy and HIV-positive children.

Authors:  C Di Taranto; V Pietropaolo; G B Orsi; L Jin; L Sinibaldi; A M Degener
Journal:  Eur J Epidemiol       Date:  1997-09       Impact factor: 8.082

Review 2.  Polyomavirus BK infection in blood and marrow transplant recipients.

Authors:  L K Dropulic; R J Jones
Journal:  Bone Marrow Transplant       Date:  2007-10-22       Impact factor: 5.483

3.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

4.  Experimental expression in mice and spontaneous expression in human SLE of polyomavirus T-antigen. A molecular basis for induction of antibodies to DNA and eukaryotic transcription factors.

Authors:  O P Rekvig; U Moens; A Sundsfjord; G Bredholt; A Osei; H Haaheim; T Traavik; E Arnesen; H J Haga
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

5.  Virus infections in bone marrow transplant recipients: a three year prospective study.

Authors:  C E Taylor; L Sviland; A D Pearson; M Dobb; M M Reid; J Kernahan; A W Craft; P J Hamilton; S Proctor
Journal:  J Clin Pathol       Date:  1990-08       Impact factor: 3.411

6.  Direct isolation and characterization of JC virus from urine samples of renal and bone marrow transplant patients.

Authors:  C Myers; R J Frisque; R R Arthur
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

7.  Identification of HeLa cell nuclear factors that bind to and activate the early promoter of human polyomavirus BK in vitro.

Authors:  T Chakraborty; G C Das
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

8.  Tubulointerstitial nephritis due to a mutant polyomavirus BK virus strain, BKV(Cin), causing end-stage renal disease.

Authors:  R D Smith; J H Galla; K Skahan; P Anderson; C C Linnemann; G S Ault; C F Ryschkewitsch; G L Stoner
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

9.  Human alpha-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells.

Authors:  Aisling S Dugan; Melissa S Maginnis; Joslynn A Jordan; Megan L Gasparovic; Kate Manley; Rebecca Page; Geoffrey Williams; Edith Porter; Bethany A O'Hara; Walter J Atwood
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

10.  Prevalence of the archetypal regulatory region and sequence polymorphisms in nonpassaged BK virus variants.

Authors:  M Negrini; S Sabbioni; R R Arthur; A Castagnoli; G Barbanti-Brodano
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.